Harki to Serve as Co-Investigator and Deputy Director of Medicinal Chemistry and DMPK

May 27, 2022

Dr. Daniel Harki Headshot

Minneapolis, Minn

May. 27, 2022

The University of Minnesota has received $66 million from the National Institute of Allergy and Infectious Diseases (NIAID) to establish a center to develop antiviral drugs for pandemic-level viruses, including SARS-CoV-2.

The Midwest Antiviral Drug Discovery (AViDD) Center is part of a network of nine national centers established by NIAID in response to the public health emergency caused by COVID-19.

The hub of the Center is located in Minnesota with two-thirds of the scientists located in the broader Midwest. Dr. Daniel Harki, Northrop Professor in the College of Pharmacy’s Department of Medicinal Chemistry, serves as co-Investigator and Deputy Director of the Medicinal Chemistry and Drug Metabolism and Pharmacokinetics (DMPK) Core.

Read the University’s official press release about the grant and establishment of the center.

Media Contacts

Dawn Tucker
College of Pharmacy
Eileen Omizo-Whittenberg
College of Pharmacy